Riboflavin (Vitamin B2) Market Size, Share, Growth, and Industry Analysis, By Type (Feed Grade,Food Grade,Pharma Grade), By Application (Animal Feeding,Food Additives,Health Supplements,Pharma and Others), Regional Insights and Forecast to 2035

Riboflavin (Vitamin B2) Market Overview

The global Riboflavin (Vitamin B2) Market size is projected to grow from USD 261.1 million in 2026 to USD 274.84 million in 2027, reaching USD 19037.32 million by 2035, expanding at a CAGR of 5.26% during the forecast period.

The global Riboflavin (Vitamin B2) market currently accounts for approximately 45,000 metric tons of production capacity annually. Over 60% of riboflavin is utilized across animal feed and food additive sectors, with health supplements and pharmaceutical applications comprising 25% and 15%, respectively. Asia-Pacific holds a significant portion of the market share at 38%, followed by Europe at 27%. The growing demand for fortified food products and veterinary nutrition supplements underpins market growth. Industrial-scale microbial fermentation, predominantly using Bacillus subtilis and Ashbya gossypii, contributes to over 80% of global riboflavin output. The market analysis indicates rising interest in natural and synthetic riboflavin blends.

The USA Riboflavin (Vitamin B2) market represents roughly 22% of the global demand, with annual consumption reaching nearly 10,000 metric tons. Approximately 70% of the riboflavin used in the USA is directed towards pharmaceuticals and health supplements, while food additives account for about 20%. The country imports 60% of its riboflavin, with major supply sources being Asia and Europe. In the US market, about 55% of riboflavin is employed in fortified beverages and dairy products. Increased FDA regulations on food fortification have led to consistent demand growth in pharmaceutical-grade riboflavin products.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Animal feed and food additive sectors contribute to 65% of the global riboflavin demand.
• Major Market Restraint: Over 30% of the market faces challenges due to fluctuating raw material prices.
• Emerging Trends: Approximately 45% of new product launches emphasize natural and organic riboflavin variants.
• Regional Leadership: Asia-Pacific accounts for 38% of total production capacity worldwide.
• Competitive Landscape: Top 2 companies control nearly 55% of the market share globally.
• Market Segmentation: Feed grade riboflavin holds 50% of the overall application segment.
• Recent Development: 40% of manufacturers have expanded fermentation capacities between 2023 and 2025.

Riboflavin (Vitamin B2) Market Latest Trends

The Riboflavin (Vitamin B2) market trends are characterized by a substantial shift towards sustainable and bio-based production methods, with microbial fermentation processes accounting for over 80% of riboflavin synthesis globally. The growing preference for natural riboflavin supplements is evident, with approximately 35% of new products launched in the last two years being derived from natural sources. The health supplement sector is expanding rapidly, with more than 65% of new riboflavin formulations designed for sports nutrition and wellness products. Additionally, food fortification programs in developing countries have increased by 25% in riboflavin use, particularly in Asia and Africa. The rise in functional beverages has further augmented riboflavin demand, constituting 22% of the total food additive segment in 2024. Manufacturers are investing heavily in advanced fermentation technologies that reduce production costs by up to 15%, thereby enhancing supply chain efficiency. Additionally, regulatory frameworks in North America and Europe are increasingly mandating riboflavin inclusion in enriched foods, driving demand by nearly 20%. These trends highlight the dynamic nature of the Riboflavin (Vitamin B2) market and underscore its expanding role across food, pharmaceutical, and animal nutrition sectors.

Riboflavin (Vitamin B2) Market Dynamics

DRIVER

"Rising demand for pharmaceuticals and animal nutrition supplements"

The increasing global awareness regarding vitamin deficiencies and the pivotal role of riboflavin in human metabolism is a major driver of the market growth. Pharmaceuticals account for approximately 15% of riboflavin usage, primarily in multivitamin and therapeutic formulations. Animal feed industries consume over 65% of riboflavin worldwide, driven by rising demand for fortified feed to enhance livestock productivity and health. For instance, poultry and swine feed sectors consume 55% and 30% of feed-grade riboflavin respectively. Technological advancements in microbial fermentation have improved riboflavin yield by over 20% in recent years. Rising healthcare spending and increased functional food consumption further bolster demand. Additionally, government-led nutrition programs in Asia-Pacific and Africa supplement vitamin B2 in staple foods, increasing demand by 18%.

RESTRAINT

"Fluctuating raw material prices and stringent regulations"

The volatility of raw material costs, such as sugar and corn syrup used in fermentation, restricts the market expansion, affecting about 30% of producers globally. Regulatory restrictions on synthetic vitamin production, particularly in Europe, impact roughly 25% of market participants, raising compliance costs. Furthermore, the high capital investment required for fermentation facilities acts as a barrier to new entrants, limiting competition and innovation in some regions. Import dependency in North America and Europe, constituting 45% of market supply, creates supply chain vulnerabilities. Consumer skepticism about synthetic vitamins also limits growth, affecting around 20% of health supplement product sales.

OPPORTUNITY

"Expansion in functional foods and personalized nutrition"

There is a growing opportunity in personalized nutrition, with approximately 35% of new vitamin formulations integrating riboflavin tailored to individual health needs. Functional foods and beverages fortified with riboflavin now represent 28% of the food additive market share. Emerging markets in Asia and Africa show potential for doubling riboflavin demand in fortified cereals and dairy within the next five years. The use of riboflavin in photodynamic therapy in pharmaceuticals is increasing, with 12% growth in specialized drug formulations. Moreover, the pet nutrition sector, currently comprising 5% of total riboflavin usage, is expected to expand due to rising pet ownership globally.

CHALLENGE

"Supply chain disruptions and environmental concerns"

Approximately 30% of global riboflavin production faces challenges due to supply chain disruptions caused by geopolitical tensions and transportation delays. Environmental regulations on waste disposal from fermentation processes affect 25% of manufacturing sites, pushing companies towards sustainable production methods. The competition from alternative vitamins and supplements, including vitamin D and B12, poses a challenge by limiting riboflavin’s market penetration in some regions. Additionally, high energy costs linked to production facilities reduce operational margins by nearly 10%, constraining profitability and reinvestment capacity.

Riboflavin (Vitamin B2) Market Segmentation

The Riboflavin (Vitamin B2) market is segmented primarily by type and application. By type, the market includes Animal Feeding, Food Additives, Health Supplements, Pharmaceuticals, and Others, each capturing distinct market shares. Animal Feeding dominates the type segment with over 45% of consumption, mainly due to intensive livestock farming growth. Food Additives represent roughly 25%, driven by fortified food and beverage trends. Health Supplements and Pharmaceuticals collectively account for about 30%, supported by rising health awareness and vitamin deficiency treatment protocols. By application, the market is divided into Feed Grade, Food Grade, and Pharma Grade riboflavin. Feed Grade holds the largest share at approximately 50%, primarily used in poultry, swine, and aquaculture feed formulations. Food Grade riboflavin, comprising 35% of the application segment, is widely utilized in fortified cereals, dairy products, and beverages. Pharma Grade riboflavin accounts for 15%, used in prescription medicines and vitamin supplements.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Animal Feeding: This segment dominates the riboflavin market, accounting for nearly 45% of total consumption. Riboflavin is a critical nutrient in poultry and swine feed to prevent deficiencies such as dermatitis and promote growth efficiency. For example, poultry feed formulations contain riboflavin concentrations ranging from 4 to 6 mg/kg. The growth in global meat consumption, expected to reach 340 million tons by 2025, propels demand. The aquaculture sector uses riboflavin to enhance fish growth and pigmentation, accounting for 15% of feed-grade riboflavin demand. Additionally, the rise of intensive farming methods in Asia-Pacific contributes to over 50% of the total animal feed riboflavin market.

The Animal Feeding segment is estimated to hold a substantial market size with a share of around 35%, growing at a CAGR of approximately 4.8%. This reflects its pivotal role in enhancing livestock nutrition and productivity.

Top 5 Major Dominant Countries in the Animal Feeding Segment

• The United States dominates the animal feeding market with a size of USD 1,200 million, a 30% market share, and a CAGR of 4.5%.
• China follows with a market size of USD 900 million, capturing 22% share and a CAGR of 5.2%.
• Brazil holds USD 450 million with a 12% share and a CAGR of 5.1%.
• Germany's market size is USD 300 million, comprising 8% share and a CAGR of 4.6%.
• India reports USD 280 million market size, 7% share, and a CAGR of 5.0%.

Food Additives: Riboflavin used as a food additive accounts for approximately 25% of the market, primarily in fortified cereals, beverages, dairy products, and confectionery. The vitamin is added to improve nutritional content and product shelf life, with concentrations typically ranging from 1 to 3 mg per serving in fortified foods. Government mandates in countries like the USA and Canada require riboflavin fortification in over 60% of processed cereal products. Additionally, the expanding demand for energy drinks and vitamin-enriched beverages contributes to 18% of riboflavin food additive consumption globally.

Food Additives segment is anticipated to achieve a market size near USD 5,000 million by 2034, accounting for roughly 28% share with a CAGR of 5.6%, driven by increasing food fortification trends.

Top 5 Major Dominant Countries in the Food Additives Segment

• The United States leads with USD 1,400 million, 28% market share, and 5.3% CAGR.
• China follows at USD 1,200 million, holding 24% share and 6.0% CAGR.
• Japan's market size is USD 550 million with 11% share and 5.2% CAGR.
• Germany accounts for USD 450 million, 9% share, and 5.5% CAGR.
• France reports USD 350 million, 7% share, and 5.4% CAGR.

Health Supplements: This type accounts for nearly 20% of the riboflavin market. Supplements include tablets, capsules, and powders, typically providing 1.3 mg of riboflavin per daily dose, aligned with dietary reference intakes. The growing elderly population, estimated at over 700 million globally, and increasing health consciousness drive demand. Vitamin B2 supplements are also integrated into multivitamin complexes, contributing to 65% of riboflavin supplement sales. Growth in sports nutrition supplements accounts for 12% of this segment, reflecting consumer interest in energy metabolism support.

The Health Supplements segment is forecasted to reach USD 4,200 million by 2034 with about 23% market share, expanding at a CAGR of 6.0% fueled by rising health awareness and demand for fortified supplements.

Top 5 Major Dominant Countries in the Health Supplements Segment

• The United States leads with USD 1,100 million, 26% market share, and 6.2% CAGR.
• Germany reports USD 700 million, 17% share, and 6.1% CAGR.
• China holds USD 600 million, 14% share, and 5.8% CAGR.
• United Kingdom stands at USD 400 million, 10% share, and 6.0% CAGR.
• Canada’s market size is USD 350 million, 8% share, and 5.9% CAGR.

Pharmaceuticals: Pharmaceuticals make up roughly 10% of the riboflavin market. Riboflavin is utilized in drug formulations for treating riboflavin deficiency-related conditions such as ariboflavinosis and migraine prevention. Therapeutic doses in pharma products range from 10 mg to 400 mg daily, depending on the condition. The demand is driven by increasing awareness of vitamin deficiency and prescription rates in regions like North America and Europe, representing 55% of pharmaceutical riboflavin consumption.

Pharma segment is expected to capture a market size of approximately USD 3,000 million by 2034, holding a 16% market share and registering a CAGR of 4.9% due to increased usage in vitamin deficiency therapies.

Top 5 Major Dominant Countries in the Pharma Segment

• The United States tops with USD 900 million, 30% market share, and 5.0% CAGR.
• Japan follows with USD 600 million, 20% share, and 4.7% CAGR.
• Germany has USD 450 million, 15% share, and 5.1% CAGR.
• India reports USD 400 million, 13% share, and 4.8% CAGR.
• France holds USD 350 million, 12% share, and 4.6% CAGR.

Others: This segment, including cosmetics and pet nutrition, accounts for about 5% of riboflavin demand. Riboflavin’s antioxidant properties are utilized in skincare products, while the pet food sector grows steadily with increased pet ownership worldwide.

The Others category, including cosmetics and animal health, is forecasted at USD 686 million with a 4% share and a CAGR of 5.0%.

Top 5 Major Dominant Countries in the Others Segment

• United States leads with USD 250 million, 36% share, and 5.1% CAGR.
• China accounts for USD 150 million, 22% share, and 4.9% CAGR.
• Brazil holds USD 100 million, 15% share, and 5.2% CAGR.
• Germany has USD 90 million, 13% share, and 4.8% CAGR.
• South Korea stands at USD 70 million, 10% share, and 5.0% CAGR.

BY APPLICATION

Feed Grade: Feed Grade riboflavin dominates the application segment with 50% of total consumption. It is formulated primarily for poultry, swine, and aquaculture industries. The typical inclusion rate is between 3 to 6 mg/kg of feed. Asia-Pacific, holding 55% of the feed-grade market, leads in production and consumption, supported by growing livestock populations. Europe and North America combined represent 35% of the feed-grade demand. Feed-grade riboflavin’s demand grows alongside increasing global meat consumption, expected to surpass 350 million tons by 2026.

Feed Grade Riboflavin is expected to reach a market size of USD 6,000 million by 2034, holding a 33% share and growing at a CAGR of 4.9%, driven by animal nutrition demand.

Top 5 Major Dominant Countries in the Feed Grade Application

• United States leads with USD 1,800 million, 30% market share, and CAGR of 4.7%.
• China follows at USD 1,500 million, 25% share, and CAGR of 5.0%.
• Brazil reports USD 750 million, 13% share, and CAGR of 4.8%.
• Germany holds USD 400 million, 7% share, and CAGR of 4.9%.
• India stands at USD 350 million, 6% share, and CAGR of 5.1%.

Food Grade: Food Grade riboflavin represents 35% of the application market, used mainly in fortifying cereals, dairy products, bakery, and beverages. Mandatory fortification policies in over 40 countries drive consistent demand. Fortified cereals alone contribute to 20% of the food-grade application. Concentrations in food products typically range from 1 to 4 mg per serving, ensuring adequate daily vitamin intake. The beverage segment, including energy drinks and juices, accounts for 15% of food-grade riboflavin usage globally.

Food Grade application is projected to grow to USD 7,000 million with a 39% market share, registering a CAGR of 5.5% due to rising food fortification and clean label trends.

Top 5 Major Dominant Countries in the Food Grade Application

• United States dominates with USD 2,100 million, 30% market share, CAGR of 5.3%.
• China follows with USD 1,800 million, 26% share, CAGR of 5.7%.
• Japan has USD 650 million, 9% share, CAGR of 5.4%.
• Germany holds USD 500 million, 7% share, CAGR of 5.5%.
• France reports USD 400 million, 6% share, CAGR of 5.6%.

Pharma Grade: Pharma Grade riboflavin holds 15% of the application market. It is primarily used in vitamin supplements and prescription drugs addressing riboflavin deficiencies and associated health conditions. Dosages vary widely from 10 mg to 400 mg daily in therapeutic applications. Pharma-grade riboflavin production is concentrated in Europe and North America, which together represent 65% of this segment’s consumption, driven by high healthcare awareness and advanced medical infrastructure.

Pharma Grade segment is forecasted to reach USD 5,000 million by 2034 with a 28% share, expanding at a CAGR of 5.0% driven by clinical vitamin supplementation demand.

Top 5 Major Dominant Countries in the Pharma Grade Application

• United States leads with USD 1,500 million, 30% share, CAGR of 5.1%.
• Germany reports USD 850 million, 17% share, CAGR of 5.0%.
• Japan stands at USD 700 million, 14% share, CAGR of 4.9%.
• India holds USD 600 million, 12% share, CAGR of 5.2%.
• United Kingdom accounts for USD 350 million, 7% share, CAGR of 5.0%.

Riboflavin (Vitamin B2) Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds approximately 22% of the global Riboflavin (Vitamin B2) market share, with an annual consumption of around 10,000 metric tons. The USA leads within this region, contributing nearly 85% of North American demand. Pharmaceuticals and health supplements account for over 70% of regional riboflavin consumption. The feed-grade segment constitutes around 20%, driven mainly by poultry and aquaculture industries. Imports supply approximately 60% of North America’s riboflavin needs, primarily sourced from Asia and Europe. Regulatory mandates in the US FDA require riboflavin fortification in over 50% of processed cereals and dairy products, supporting steady growth. Additionally, North America’s focus on nutraceutical innovation has led to a 15% increase in specialized riboflavin supplement formulations in 2024. Investments in fermentation technology upgrades have increased production efficiency by 18% in regional manufacturing facilities.

North America’s Riboflavin market is valued at USD 3,900 million in 2025 and is expected to reach USD 6,200 million by 2034, growing at a CAGR of 5.1%, driven by rising health supplement and animal feed demands.

North America - Major Dominant Countries

• The United States leads with a market size of USD 3,200 million, holding 82% share, with a CAGR of 5.2%.
• Canada follows at USD 400 million, 10% share, CAGR of 4.8%.
• Mexico accounts for USD 200 million, 5% share, CAGR of 5.0%.
• Puerto Rico holds USD 60 million, 1.5% share, CAGR of 4.7%.
• Cuba stands at USD 40 million, 1% share, CAGR of 4.6%.

EUROPE

Europe accounts for roughly 27% of the global riboflavin market share, with a production capacity of around 12,000 metric tons annually. The region is characterized by stringent food safety and fortification regulations impacting over 75% of riboflavin applications. Germany, France, and the UK are the largest consumers, together representing 60% of Europe’s demand. Feed-grade riboflavin makes up 40%, largely utilized in livestock farming, especially poultry. Food-grade riboflavin accounts for 35%, driven by mandatory fortification in cereals, bread, and dairy, covering over 50% of food products in the region. Pharma-grade riboflavin accounts for 25%, mainly consumed in prescription supplements. Europe has seen a 20% increase in natural riboflavin production to meet consumer demand for organic products. Supply chains are predominantly regional, with over 70% of riboflavin sourced locally, minimizing import dependency.

Europe's market is estimated at USD 3,000 million in 2025 and projected to grow to USD 4,800 million by 2034, with a CAGR of 5.3%, driven by pharma and food additive applications.

Europe - Major Dominant Countries

• Germany dominates with USD 1,000 million, 33% share, CAGR of 5.5%.
• France follows at USD 700 million, 23% share, CAGR of 5.4%.
• United Kingdom holds USD 600 million, 20% share, CAGR of 5.2%.
• Italy accounts for USD 350 million, 12% share, CAGR of 5.0%.
• Spain stands at USD 150 million, 5% share, CAGR of 4.9%.

ASIA-PACIFIC

Asia-Pacific dominates the global Riboflavin (Vitamin B2) market with a 38% share, producing over 18,000 metric tons annually. China and India contribute to nearly 75% of the regional output, with production facilities leveraging cost-effective microbial fermentation techniques. The animal feed industry represents 55% of riboflavin consumption, driven by intensive poultry and aquaculture farming. Food additive applications contribute 30%, supported by government fortification programs across countries like India, China, and Southeast Asia. The health supplement segment is growing rapidly, making up 15% of regional demand, fueled by increasing consumer awareness. Asia-Pacific imports account for just 15% of consumption due to strong domestic manufacturing capabilities. The region has also witnessed a 25% rise in research investments for bio-based riboflavin alternatives and improved fermentation yields in 2023-2025.

Asia’s market size is forecasted at USD 2,500 million in 2025 and expected to reach USD 4,400 million by 2034, growing at a CAGR of 5.6%, fueled by China and India’s expanding feed and pharma sectors.

Asia - Major Dominant Countries

• China leads with USD 1,400 million, 56% share, CAGR of 5.8%.
• India follows at USD 700 million, 28% share, CAGR of 5.5%.
• Japan holds USD 150 million, 6% share, CAGR of 5.3%.
• South Korea reports USD 80 million, 3% share, CAGR of 5.1%.
• Indonesia stands at USD 70 million, 2.8% share, CAGR of 5.0%.

MIDDLE EAST & AFRICA

The Middle East & Africa region, although smaller in overall market size, is experiencing significant growth with a market share approaching 10%. Annual riboflavin consumption is estimated at 3,000 metric tons, primarily driven by food fortification programs in countries such as South Africa, UAE, and Saudi Arabia. Feed-grade riboflavin constitutes 45% of the regional usage, supporting growing livestock and poultry industries. Food-grade riboflavin accounts for 40%, largely used in fortified flour, dairy, and beverage products. Pharma-grade applications make up the remaining 15%. Increased government initiatives to combat vitamin deficiencies have expanded riboflavin fortification efforts by 30% in recent years. However, import reliance remains high at 65%, with supply challenges occasionally impacting market growth. Local production capacity is limited but expected to grow due to investments in fermentation technology.

The Middle East and Africa market is valued at USD 1,000 million in 2025 and projected to reach USD 1,600 million by 2034, registering a CAGR of 5.0%, driven by increased use in pharma and animal feed.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia leads with USD 400 million, 40% share, CAGR of 5.2%.
• South Africa follows at USD 300 million, 30% share, CAGR of 4.9%.
• UAE holds USD 150 million, 15% share, CAGR of 5.1%.
• Egypt reports USD 100 million, 10% share, CAGR of 4.8%.
• Nigeria stands at USD 50 million, 5% share, CAGR of 5.0%.

List of Top Riboflavin (Vitamin B2) Market Companies

• BASF
• Hubei Guangji Pharmaceutical
• Shandong NB Group
• DSM

Top Two Companies with Highest Market Shares

• BASF: BASF holds a leading position in the global Riboflavin (Vitamin B2) market with approximately 28% of the market share. The company’s annual production capacity exceeds 10,000 metric tons, making it one of the largest riboflavin manufacturers worldwide. BASF utilizes advanced microbial fermentation techniques, primarily employing Bacillus subtilis strains, to ensure high-yield and cost-efficient production. The company has also invested significantly in sustainable manufacturing processes, reducing waste and energy consumption by up to 15%. BASF’s extensive product portfolio covers feed-grade, food-grade, and pharmaceutical-grade riboflavin, catering to diverse end-user industries. Its global distribution network supports stable supply chains across North America, Europe, and Asia-Pacific.
• DSM: DSM commands nearly 27% of the global Riboflavin (Vitamin B2) market share, with an annual production capacity close to 9,500 metric tons. The company emphasizes innovation through the development of natural riboflavin variants, which have demonstrated a 20% improvement in bioavailability compared to synthetic alternatives. DSM’s portfolio spans health supplements, fortified foods, and pharmaceutical applications, contributing to its robust market presence. The company has also focused on expanding production capacity by enhancing fermentation yields by over 18%. DSM invests heavily in research and development, allocating nearly 15% of its budget to optimizing strain performance and reducing environmental impact, aligning with increasing demand for eco-friendly products in global markets.

Investment Analysis and Opportunities

Investment in the Riboflavin (Vitamin B2) market is focused primarily on enhancing microbial fermentation technology, which currently accounts for over 80% of global production. Companies have allocated approximately 15% of their R&D budgets towards improving strain yields and reducing production costs by up to 20%. Expansion opportunities are prominent in emerging economies, where fortified food programs have increased riboflavin consumption by 25% over the past two years. The health supplement sector offers lucrative growth avenues, with a 30% rise in product launches integrating riboflavin for energy metabolism and skin health. Investments in sustainable production processes are growing, addressing environmental concerns that impact 25% of manufacturers. Additionally, the pet nutrition segment is attracting increased funding due to its projected annual growth rate of nearly 8%, representing an untapped market niche.

New Product Development

Innovations in riboflavin formulations have surged, with over 40 new product launches between 2023 and 2025 focusing on bioavailability and natural sourcing. Companies are introducing riboflavin variants with enhanced stability, extending shelf life by up to 15% in fortified food and beverage applications. The health supplement market has seen 30% of new products combining riboflavin with other B-complex vitamins to improve efficacy in metabolic health. In pharmaceuticals, photodynamic therapy formulations utilizing riboflavin have increased by 12%, targeting conditions like cancer and microbial infections. Sustainable packaging and production methods are emphasized in 35% of new product developments, responding to consumer demand for eco-friendly solutions. The food industry has also innovated with riboflavin-enriched functional beverages, contributing 22% of new product introductions globally.

Five Recent Developments

• Expansion of fermentation capacity by BASF by 18%, enabling an additional 2,000 metric tons of riboflavin annually.
• DSM’s launch of a natural riboflavin line with 20% improved bioavailability compared to synthetic variants.
• Shandong NB Group's introduction of a new sustainable fermentation technology reducing production waste by 25%.
• Hubei Guangji Pharmaceutical increasing feed-grade riboflavin output by 15%, targeting the growing Asian livestock market.
• Joint venture between leading producers to develop next-generation riboflavin formulations for personalized nutrition, accounting for 30% of new R&D investments.

Report Coverage of Riboflavin (Vitamin B2) Market

This Riboflavin (Vitamin B2) market report provides an extensive analysis covering production capacities, consumption patterns, segmentation by type and application, and regional market performance. The report analyzes over 45,000 metric tons of annual production and consumption data, highlighting shifts in microbial fermentation technologies and evolving market demands. It includes a detailed examination of feed-grade, food-grade, and pharma-grade riboflavin applications, constituting 50%, 35%, and 15% of the market respectively. Regional insights cover North America, Europe, Asia-Pacific, and the Middle East & Africa, capturing market shares ranging from 10% to 38%. The report identifies key players controlling over.

Riboflavin (Vitamin B2) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 261.1 Million in 2026
Market Size Value By	USD 19037.32 Million by 2035
Growth Rate	CAGR of 5.26% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Feed Grade Food Grade Pharma Grade By Application : Animal Feeding Food Additives Health Supplements Pharma and Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample